+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 3Years - 21Years
All Genders
ID05334823

Phase II Study of Anti-CD19 CAR-T Therapy pCAR-19B for Children and Adolescents with RelapsedRefractory B-Cell Acute Lymphoblastic Leukemia

Led by Chongqing Precision Biotech Co., Ltd · Updated on 2026-09-15

100

Participants Needed

16

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of pCAR-19B, an anti-CD19 CAR-T cell therapy, for children and adolescents aged 3 to 21 years with CD19-positive relapsed or refractory B-cell acute lymphoblastic leukemia. This phase II, multi-center, single-arm, open-label study focuses on patients whose leukemia has not responded to prior treatments or has relapsed. The study aims to assess the response rate and other outcomes after treatment with the investigational therapy. Participants will first have their lymphocytes collected through leukapheresis. After the collected cells are prepared into pCAR-19B cells, patients will receive lymphodepleting chemotherapy with cyclophosphamide and fludarabine for three consecutive days. This is followed by an intravenous infusion of the pCAR-19B cells at a targeted dose. The treatment period includes careful administration and monitoring of this cell infusion. Throughout the study, participants will undergo assessments including bone marrow evaluations, blood tests, and monitoring for adverse effects and response to treatment. Researchers will measure outcomes such as objective response rate at three months, minimal residual disease, overall survival, duration of response, relapse-free survival, and event-free survival over two years. Safety data and pharmacokinetic and pharmacodynamic parameters will also be collected. The study is planned to complete by mid-2029.

CONDITIONS

Brief Title

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Research Team

T

Tianyou Wang, M.D

Y

Yicheng Zhang, M.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here